Anvisa said the trial of the vaccine – which is being developed by the Chinese biopharmaceutical firm Sinovac Biotech – had been suspended as a result of a “adverse, serious event” involving a participant in Brazil. But many Bolsonaro critics see a possible political motivation behind the move, and the head of the Brazilian research centre coordinating the trial claimed the volunteer’s death was not related to the vaccine.
The broadcaster TV Cultura reported on Tuesday that the “event” was suicide, saying it had seen the coroner’s report showing the trial volunteer had taken their own life.
